Menu

ISTOCK, SEZERYADIGAR

Arrests, Investigations Over Vaccine Scandal in China

Changsheng is found to have forged records for a rabies vaccine and is accused of distributing thousands of substandard DPT immunizations to be used in children.

Jul 27, 2018
Kerry Grens

Vaccine maker Changsheng fudged documentation on the quality of materials used in its rabies vaccine and violated the law, a Chinese government investigation has found. The conclusion comes as 15 people, including the chair of the company, are arrested on “suspicion of criminal offences,” Al Jazeera reports.

“The company used expired materials to produce some rabies vaccine and falsified the production date,” according to a government investigation cited by Reuters. “To cover up violations, the company systematically fabricated production and testing records.”

The fallout from the falsified records on the rabies vaccines comes amid news about another serious lapse by Changsheng in which it allegedly sold more than 250,000 doses of an ineffective diphtheria, pertussis, and tetanus (DPT) vaccine.

Problems emerged with Changsheng’s products last year, when China’s regulatory authority found the DPT vaccine to be subpar. Then this summer, Changsheng voluntarily recalled its rabies vaccine after admitting to falsifying records.

Together, the scandals have sown distrust among parents. “We always say that kids are the nation’s future, but if we can’t ensure the safety of such a future, what does the future hold for us?” Huo Xiaoling, whose 1-year-old daughter received a vaccine made by Changsheng, tells The New York Times. She adds that she won’t buy any more Chinese-made vaccines.

The Times notes that there is no evidence anyone has been hurt by the DPT vaccines.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening